A Randomized Clinical Trial to evaluate the effectiveness of Millesimal and Centesimal Potencies of Homoeopathic Medicines in the management of Pyrexia in Adults Using FAST Tool
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- To evaluate the degree of fever reduction by fifty millesimal potency and centesimal potency .
Study Overview
Brief Summary
In Homoeopathy, acute diseases are classified into epidemic outbreaks, sporadic instances, and uniquely individual cases. The ideal Homoeopathic treatment hinges on a comprehensive understanding of the characteristic symptoms presented by the patient. This is complemented by identifying the root cause of the disease’s exciting factor. Any changes or deviations in the patient’s overall health, often termed ‘altered generals’, are also given prime consideration.
However, certain aspects remain debated even within the well-defined boundaries of Homoeopathic practice. One such aspect is selection of required potency. Finding the right balance and determining the most effective dose is crucial, especially when the stakes are as high as they are with fever management.
The scales used for prescription are decimal, centesimal and millesimal. Among these decimal and centesimal potencies are widely used and well proven. But certain debates are going on the path of millesimal scale. The fifty millesimal scale or the LM scale was introduced in the sixth edition of Organon of medicine in the year 1921 mainly for the reason that remedies may be required to be repeated. In order to decrease the drug quantity in the dose and to minimalise aggravation even during the management of chronic diseases, this particular scale was introduced.
The primary reason for the different opinions is that the concept was published after the death of master Hahnemann. As a result many of the practitioners are reluctant in accepting the scale. As a result worldwide research for validating the utility and the scope of this scale is not done extensively when comparing with the other two scales.
This research seeks to navigate this complex terrain. The primary objective is to analyse the efficiency of fifty millesimal potency and centesimal potency in fever management within the homoeopathic context. Also the speed of recovery in both of the scales is evaluated and compared. By shedding light on this subject, the study aims to clarify and chart a more straightforward path for practitioners in the area of management of acute pyrexia.
The Organon of Medicine provides a comprehensive account of treating acute diseases using homoeopathic medicines. The Central Council for Research in Homeopathy (CCRH) has actively explored the efficacy of Homoeopathy in managing acute diseases, leading to the publication of numerous articles. Notably, the CCRH Best Dissertation Awards recognize outstanding studies on homoeopathic medicines in the context of acute and chronic diseases. This research also aims to substantiate the effectiveness of homoeopathic medicines, specifically in treating fever.
Study Design
- Study Type
- Interventional
- Allocation
- Other
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Patients of age group between 18 – 60 yrs.
- •2.Both sexes 3.Diagnostic criteria are mainly based on the clinical presentation.
Exclusion Criteria
- •1.Patients below 18 yrs. 2.Adults above 60 yrs.
- •3.Temperature above 102.2 °F 4.Patients who reported after twenty four hours of onset.
- •5.Patients who have taken medications other than Homoeopathic prescription for the same.
- •6.Patients who are suffering from life-threatening diseases, advanced stages of long-standing diseases.
- •7.Patients who are immune-compromised .
- •8.Patients who fails to get betterment of temperature parameters within maximum of two hour after administration of first dose.
Outcomes
Primary Outcomes
To evaluate the degree of fever reduction by fifty millesimal potency and centesimal potency .
Time Frame: One year and three months
Secondary Outcomes
- To compare the efficacy of fever reduction in millesimal and centesimal potencies.(one year three and months)
- To assess patient satisfaction and comfort using FAST tool.(one year and three months)
- To evaluate the speed of recovery in both of the potency scales using FAST tool.(one year and three months)
- To gauge the ease of administration for healthcare professionals.(one year and three months)
Investigators
Dr Jeswin Abraham
Vinayaka Missions Homoeopathic Medical College and Hospital